Patheon to Showcase API Development Capabilities at InformEx
Patheon will display its late-stage API development capabilities at InformEx.
Patheon, a provider of contract development and commercial manufacturing services, will showcase its late-stage API development capabilities at InformEx in Miami, Fla., January 21-24, 2014. In addition, many Patheon executives as well as technical and scientific professionals will also attend InformEx and will be available to discuss Patheon's API development capabilities. Patheon will be exhibiting at Booth #1010 for the duration of the conference. InformEx offers participants a direct view of what is happening globally across the fine, specialty, and custom chemical marketplace. The event brings together an international mix of buyers and sellers for four days of sourcing, education, and networking.
Source: Patheon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
